TIAA CREF Investment Management’s Fate Therapeutics FATE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
$1.76M Sell
2018
Q4
$1.29M Buy
2018
Q3
$1.52M Sell
2018
Q2
$1.1M Sell
2018
Q1
$1.01M Buy
2017
Q4
$588K Sell
2017
Q3
$404K Sell
2017
Q2
$373K Buy